Preparation and Characterization of Gelatin-Based Mucoadhesive Nanocomposites as Intravesical Gene Delivery Scaffolds

被引:20
作者
Liu, Ching-Wen [1 ]
Chang, Li-Ching [2 ,3 ]
Lin, Kai-Jen [4 ]
Yu, Tsan-Jung [5 ]
Tsai, Ching-Chung [1 ,6 ]
Wang, Hao-Kuang [7 ]
Tsai, Tong-Rong [1 ]
机构
[1] Kaohsiung Med Univ, Sch Pharm, Kaohsiung 807, Taiwan
[2] I Shou Univ, Dept Occupat Therapy, Kaohsiung 824, Taiwan
[3] I Shou Univ, E DA Hosp, Dept Pharm, Kaohsiung 824, Taiwan
[4] I Shou Univ, E DA Hosp, Dept Pathol, Kaohsiung 824, Taiwan
[5] I Shou Univ, E DA Hosp, Dept Urol, Kaohsiung 824, Taiwan
[6] I Shou Univ, E DA Hosp, Dept Pediat, Kaohsiung 824, Taiwan
[7] I Shou Univ, E DA Hosp, Dept Neurosurg, Kaohsiung 824, Taiwan
关键词
BLADDER-CANCER; DRUG-DELIVERY; HYALURONIC-ACID; HYDROGELS; NANOPARTICLES;
D O I
10.1155/2014/473823
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
This study aimed to develop optimal gelatin-based mucoadhesive nanocomposites as scaffolds for intravesical gene delivery to the urothelium. Hydrogels were prepared by chemically crosslinking gelatin A or B with glutaraldehyde. Physicochemical and delivery properties including hydration ratio, viscosity, size, yield, thermosensitivity, and enzymatic degradation were studied, and scanning electron microscopy (SEM) was carried out. The optimal hydrogels (H), composed of 15% gelatin A175, displayed an 81.5% yield rate, 87.1% hydration ratio, 42.9 Pa.s viscosity, and 125.8 nm particle size. The crosslinking density of the hydrogels was determined by performing pronase degradation and ninhydrin assays. In vitro lentivirus (LV) release studies involving p24 capsid protein analysis in 293T cells revealed that hydrogels containing lentivirus (H-LV) had a higher cumulative release than that observed for LV alone (3.7-, 2.3-, and 2.3-fold at days 1, 3, and 5, resp.). Lentivirus from lentivector constructed green fluorescent protein (GFP) was then entrapped in hydrogels (H-LV-GFP). H-LV-GFP showed enhanced gene delivery in AY-27 cells in vitro and to rat urothelium by intravesical instillation in vivo. Cystometrogram showed mucoadhesive H-LV reduced peak micturition and threshold pressure and increased bladder compliance. In this study, we successfully developed first optimal gelatin-based mucoadhesive nanocomposites as intravesical gene delivery scaffolds.
引用
收藏
页数:12
相关论文
共 32 条
[21]   Hydrogels for lentiviral gene delivery [J].
Seidlits, Stephanie K. ;
Gower, Robert Michael ;
Shepard, Jaclyn A. ;
Shea, Lonnie D. .
EXPERT OPINION ON DRUG DELIVERY, 2013, 10 (04) :499-509
[22]   Intravesical treatments of bladder cancer: Review [J].
Shen, Zancong ;
Shen, Tong ;
Wientjes, M. Guillaume ;
O'Donnell, Michael A. ;
Au, Jessie L. -S. .
PHARMACEUTICAL RESEARCH, 2008, 25 (07) :1500-1510
[23]   Lentivirus Immobilization to Nanoparticles for Enhanced and Localized Delivery From Hydrogels [J].
Shin, Seungjin ;
Shea, Lonnie D. .
MOLECULAR THERAPY, 2010, 18 (04) :700-706
[24]  
Sung HW, 1999, J BIOMED MATER RES, V46, P520
[25]   Sustained intravesical drug delivery using thermosensitive hydrogel [J].
Tyagi, P ;
Li, ZH ;
Chancellor, M ;
De Groat, WC ;
Yoshimura, N ;
Huang, L .
PHARMACEUTICAL RESEARCH, 2004, 21 (05) :832-837
[26]   Recent advances in intravesical drug/gene delivery [J].
Tyagi, Pradeep ;
Wu, Pao-Chu ;
Chancellor, Michael ;
Yoshimura, Naoki ;
Huang, Leaf .
MOLECULAR PHARMACEUTICS, 2006, 3 (04) :369-379
[27]   Non-viral vector delivery from PEG-hyaluronic acid hydrogels [J].
Wieland, Julie A. ;
Houchin-Ray, Tiffany L. ;
Shea, Lonnie D. .
JOURNAL OF CONTROLLED RELEASE, 2007, 120 (03) :233-241
[28]   Biodistribution of an adenoviral vector carrying the luciferase reporter gene following intravesical or intravenous administration to a mouse [J].
Wood, M ;
Perrotte, P ;
Onishi, E ;
Harper, ME ;
Dinney, C ;
Pagliaro, L ;
Wilson, DR .
CANCER GENE THERAPY, 1999, 6 (04) :367-372
[29]   Increasing Mechanical Strength of Gelatin Hydrogels by Divalent Metal Ion Removal [J].
Xing, Qi ;
Yates, Keegan ;
Vogt, Caleb ;
Qian, Zichen ;
Frost, Megan C. ;
Zhao, Feng .
SCIENTIFIC REPORTS, 2014, 4
[30]  
Zhang Bing, 2004, Genet Vaccines Ther, V2, P6, DOI 10.1186/1479-0556-2-6